I-MED Pharma Inc.
Daniel H. is a highly experienced executive who currently serves as the Chief Executive Officer at I-MED Pharma Inc. Their career has included various leadership roles, such as Vice President at Efficacité M.D. and Key Accounts Manager at Allerpharma. With an educational background in Biochemistry and a MBA in Marketing and Strategy, Daniel is well-equipped to lead and shape company culture to achieve long-term goals. Additionally, their roles as a Member of the Board at Atelier JEM Workshop and Preventia Technologies demonstrate their commitment to diverse industries and business development.
I-MED Pharma Inc.
Specializing in dry eye diagnosis and management for over 30 years, I-MED Pharma provides ocular surface disease (OSD) solutions to Canadian ophthalmologists, optometrists, and the global eye care community. Our mission is to bring complete relief to dry eye and OSD patients worldwide. To do this, we continually research and develop the most effective and advanced solutions for dry eye disease. I-MED Pharma offers a complete range of ocular surface disorder products, including diagnostic tools, artificial tears, ocular hygiene cleansers, IRPL® treatment solutions, punctum plugs, nutritional supplements, and therapeutic accessories. www.imedpharma.com